- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Enzon Pharmaceuticals Inc+ Add to Watchlist
ENZN:US3.1700 USD 0.0100 0.31%
As of 20:10:00 ET on 05/17/2013.
Company Profile for Enzon Pharmaceuticals Inc (ENZN)
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.
Enzon Pharmaceuticals Inc
Key Executives for Enzon Pharmaceuticals Inc (ENZN)
|Ralph Del CampoChief Operating Officer||Andrew RackearChief Compliance Ofcr/Secy|
|Charles ConoverSenior VP:Research & Development||Timothy G DalyVP/Chief Acctg Ofcr/Controller|